Health
Nivolumab and Chemotherapy for Mesothelioma is Focus of New Trial – Surviving Mesothelioma
Researchers in Germany are recruiting patients for a trial of nivolumab and chemotherapy for pleural mesothelioma patients after surgery.
Researchers in Germany are recruiting patients for a trial of nivolumab and chemotherapy for pleural mesothelioma patients who have had surgery.
Nivolumab (Opdivo) is an immunotherapy drug similar to pembrolizumab (Keytruda). It blocks a protein that helps mesothelioma cells hide from the immune system. Nivolumab is most often used for patients with non-small cell lung cancer.
The multicenter German study will test if a combination of nivolumab and chemotherapy can help keep tumors from growing…
-
Noosa News18 hours agoWhat led to the giant, damaging hail which smashed parts of Queensland over the weekend?
-
Noosa News20 hours agoMotorbike rider cops massive fine after doing a wheelie right in front of police
-
General21 hours agoNew York Marathon won by Benson Kipruto wins in classic photo finish, Eliud Kipchoge announces final tour
-
General23 hours agoAustralia’s Kimberly Birrell loses Chennai Open final but earns sportsmanship award